Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 23, 2025, inter alia, considered and approved the following matters:1. Audited Standalone Financial Results of the Company for the Quarter and Year ended on 31st March, 2025 together with a Statement of Cash Flow, Statement of Assets and Liabilities for the same period;2. Auditors Report on the said Financial Results;
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.1 pts more than its Edible Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
M K Proteins Limited has informed the stock exchanges that its Board of Directors met on Friday, May 23, 2025, and approved the audited standalone financial results for the quarter and full year ended March 31, 2025. Along with the results, the Board also approved the Statement of Cash Flow and the Statement of Assets and Liabilities for the same period. The Auditors' Report on these financial results was also taken on record at the same meeting. The actual financial numbers, including revenue, profit, and segment details, are not disclosed in this filing and will be available in the detailed results document.
This is a routine procedural filing confirming that the company has finalised its FY25 audited results. Shareholders should review the detailed results document for actual performance numbers, as this announcement itself does not contain any financial data or surprises.